首页> 外文期刊>Methods: A Companion to Methods in Enzymology >IMPRes-Pro: A high dimensional multiomics integration method for in silico hypothesis generation
【24h】

IMPRes-Pro: A high dimensional multiomics integration method for in silico hypothesis generation

机译:Impres-Pro:在硅假设生成中的高维多组合器集成方法

获取原文
获取原文并翻译 | 示例
           

摘要

Nowadays, large amounts of omics data have been generated and contributed to increasing knowledge about associated biological mechanisms. A new challenge coming along is how to identify the active pathways and extract useful insights from these data with huge background information and noise. Although biologically meaningful modules can often be detected by many existing informatics tools, it is still hard to interpret or make use of the results towards in silico hypothesis generation and testing. To address this gap, we previously developed the IMPRes (Integrative MultiOmics Pathway Resolution) v 1.0 algorithm, a new step-wise active pathway detection method using a dynamic programming approach. This approach enables the network detection one step at a time, making it easy for researchers to trace the pathways, and leading to more accurate drug design and more effective treatment strategies. In this paper, we present IMPRes-Pro, an enhancement to IMPRes v1.0 by integrating proteomics data along with transcriptomics data and constructing a heterogeneous background network. The evaluation experiment conducted on human primary breast cancer dataset has shown the advantage over the original IMPRes v1.0 method. Furthermore, a case study on human metastatic breast cancer dataset was performed and we have provided several insights regarding the selection of optimal therapy strategy. IMPRes-Pro algorithm and visualization tool is available as a web service at http://digbio.missouri. edu/impres.
机译:如今,已经产生了大量的OMIC数据,并有助于提高关于相关生物机制的知识。新的挑战是如何识别有源途径,并从这些数据中提取有用的洞察,其中包含巨大的背景信息和噪音。虽然许多现有的信息工具通常可以检测到生物学上有意义的模块,但仍然很难解释或利用在Silico假设产生和测试中的结果。为了解决这一差距,我们之前开发了IMPRES(综合多组合器分辨率)V 1.0算法,一种使用动态编程方法的新的逐步活动通路检测方法。这种方法能够一次实现一步的网络检测,使研究人员能够容易地追踪途径,并导致更准确的药物设计和更有效的治疗策略。在本文中,我们通过将蛋白质组学数据与转录组数据与转录组数据相结合并构建异构背景网络来呈现KMERS-Pro,增强v1.0。对人原发性乳腺癌数据集进行的评价实验表明了原始v1.0方法的优势。此外,进行了对人转移性乳腺癌数据集进行的案例研究,我们提供了有关选择最佳治疗策略的识别。 Impres-Pro算法和可视化工具可作为Http://digbio.missouri的Web服务。 edu / macks。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号